Concepedia

Publication | Open Access

Combined regimen of cisplatin, doxorubicin, and ?-2b interferon in the treatment of advanced malignant pleural mesothelioma

51

Citations

41

References

2001

Year

Abstract

This combined regimen has definite activity in MPM. However, toxicity, particularly myelosuppression and fatigue, is not negligible and may limit its application.

References

YearCitations

Page 1